dehydrocostus lactone has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Ji, W; Lin, X; Liu, C; Peng, Z; Su, C; Wang, Y; Xu, Y; Yan, C | 1 |
| Hsu, YL; Kuo, PL; Ni, WC; Tsai, EM | 1 |
2 other study(ies) available for dehydrocostus lactone and Breast Cancer
| Article | Year |
|---|---|
Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.
Topics: 14-3-3 Proteins; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclic AMP; Female; Humans; Lactones; Mice, Inbred BALB C; Mice, Nude; Oils, Volatile; Protein Interaction Maps; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Sesquiterpenes; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |
Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Janus Kinases; Lactones; Mice; Mice, Inbred BALB C; Mice, Nude; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2009 |